Pharmaceutical

Paula Deen and sons team up with drug maker to push recipes for diabetics

paula deen 435x326 Paula Deen and sons team up with drug maker to push recipes for diabetics Paula Deen and her two sons, Bobby and Jamie, are teaming up with drug maker Novo Nordisk for a national initiative aimed at helping diabetics like Paula overcome common challenges associated with type 2 diabetes management. The campaign, called Diabetes in a New Light, features recipes for lighter versions of some of Paula’s favorite summertime recipes.

Earlier this year, Paula announced she had been diagnosed with type 2 diabetes three years prior. She chose to come clean about her disease after signing a lucrative deal with Novo Nordisk to promote its type 2 diabetes drug Victoza. The celebrity chef’s announcement was met with much criticism by people who said she had been a hypocrite by showcasing fattening and sugary recipes in her cookbooks and television shows – the kinds of foods that cause people to become obese and develop type 2 diabetes.

Diabetes is a worldwide epidemic affecting 26 million people in the United States alone. It can be controlled by following a healthy diet and exercise program, though the majority of people with diabetes must rely on medication to keep their blood sugar in control.

Diabetes treatments can cause serious adverse events. In 2010, the Food and Drug Administration (FDA) placed severe restrictions on the type 2 diabetes medication Avandia because of heart risks. In 2011, the FDA warned that the type 2 diabetes drug Actos increased the risk for bladder cancer. Paula’s drug, Victoza, is no exception. It carries a risk for thyroid cancer.

Source: The Clay Times-Journal